Publication:
Effective use of mirtazapine for refractory pruritus associated with carcinoma en cuirasse

Thumbnail Image

Date

2014

Journal Title

Journal ISSN

Volume Title

Publisher

The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Lee, Jonathan J, Sasha D Girouard, Valerie M Carlberg, and Arash Mostaghimi. 2014. “Effective Use of Mirtazapine for Refractory Pruritus Associated with Carcinoma En Cuirasse.” BMJ Supportive & Palliative Care 6 (1) (December 16): 119–121. doi:10.1136/bmjspcare-2014-000790.

Research Data

Abstract

Pruritus is a debilitating symptom that can be associated with cutaneous involvement by an underlying malignancy. We report the case of a 68-year-old woman with a history of triple- negative breast cancer who presented with extensive, localised cutaneous metastasis complicated by incapacitating, treatment- refractory pruritus localised to the anatomic regions involved by her metastatic disease. Physical examination revealed an indurated, ecchymotic, ulcerated plaque circumferentially encasing her thorax. Histopathological examination revealed substantial dermal lymphatic involvement and dilation as well as dermal collagen infiltration by tumour cells and nodules. The clinical and pathological findings were consistent with a diagnosis of carcinoma en cuirasse. Mirtazapine, a noradrenergic antidepressant with antiserotonin and antihistamine activity, was started and led to rapid, sustained relief of the patient’s pruritus. Mirtazapine may be a useful systemic agent for the palliative relief of pruritus associated with cutaneous infiltration by an underlying malignancy.

Description

Other Available Sources

Keywords

Terms of Use

Metadata Only

Endorsement

Review

Supplemented By

Referenced By

Related Stories